Fundraising FoxBilix
1 known investors
Find your way into Bilix
Sign up to see every warm intro you have to Bilix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bilix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bilix develops BRIXELLE-ONCO, a bilirubin nanoparticle technology that serves as a non-toxic drug carrier for anti-cancer agents, designed to reduce side effects in cancer treatment by improving drug delivery to tumor sites. The technology uses naturally occurring bilirubin conjugated with PEG to encapsulate and deliver hydrophobic anti-cancer drugs with minimal systemic toxicity.
Investors · 1
Frequently asked questions
- What does Bilix do?
- Bilix develops BRIXELLE-ONCO, a bilirubin nanoparticle technology that serves as a non-toxic drug carrier for anti-cancer agents, designed to reduce side effects in cancer treatment by improving drug delivery to tumor sites. The technology uses naturally occurring bilirubin conjugated with PEG to encapsulate and deliver hydrophobic anti-cancer drugs with minimal systemic toxicity.
- Who are Bilix's investors?
- Bilix's investors include We Ventures.